Omega Fund Management
Latest statistics and disclosures from Omega Fund Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are KMTS, BBNX, Bridgebio Oncology Therapeut, BCAX, NUVB, and represent 82.23% of Omega Fund Management's stock portfolio.
- Added to shares of these 2 stocks: Bridgebio Oncology Therapeut (+$38M), Imagenebio.
- Started 2 new stock positions in Imagenebio, Bridgebio Oncology Therapeut.
- Reduced shares in these 8 stocks: UPB (-$13M), NUVB (-$8.2M), REPL (-$7.2M), LXEO, IKNA, BBNX, IMUX, ENGNW.
- Sold out of its positions in IKNA, IMUX, LXEO.
- Omega Fund Management was a net buyer of stock by $3.1M.
- Omega Fund Management has $222M in assets under management (AUM), dropping by 43.98%.
- Central Index Key (CIK): 0001637359
Tip: Access up to 7 years of quarterly data
Positions held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 12 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Kestra Med Technologies Common Stock (KMTS) | 17.6 | $39M | 1.6M | 23.76 |
|
|
| Beta Bionics Common Stock (BBNX) | 17.2 | $38M | -3% | 1.9M | 19.87 |
|
| BridgeBio Oncology Therapeutics Common Stock | 17.1 | $38M | NEW | 3.3M | 11.58 |
|
| Bicara Therapeutics Common Stock (BCAX) | 15.7 | $35M | 2.2M | 15.79 |
|
|
| Nuvation Bio Common Stock Class A (NUVB) | 14.7 | $33M | -20% | 8.8M | 3.70 |
|
| Upstream Bio Common Stock (UPB) | 11.5 | $26M | -33% | 1.4M | 18.81 |
|
| ImageneBio Common Stock | 1.7 | $3.7M | NEW | 455k | 8.15 |
|
| enGene Holdings Common Stock (ENGN) | 1.6 | $3.6M | 526k | 6.83 |
|
|
| Sana Biotechnology Common Stock (SANA) | 1.3 | $3.0M | 844k | 3.55 |
|
|
| Alumis Common Stock (ALMS) | 1.2 | $2.6M | 653k | 3.99 |
|
|
| Replimune Group Common Stock (REPL) | 0.5 | $1.0M | -87% | 249k | 4.19 |
|
| enGene Holdings Warrant (ENGNW) | 0.0 | $63k | -72% | 90k | 0.71 |
|
Past Filings by Omega Fund Management
SEC 13F filings are viewable for Omega Fund Management going back to 2014
- Omega Fund Management 2025 Q3 filed Nov. 14, 2025
- Omega Fund Management 2025 Q2 filed Aug. 14, 2025
- Omega Fund Management 2024 Q4 amended filed May 15, 2025
- Omega Fund Management 2025 Q1 filed May 15, 2025
- Omega Fund Management 2024 Q4 filed Feb. 14, 2025
- Omega Fund Management 2024 Q3 filed Nov. 14, 2024
- Omega Fund Management 2024 Q2 filed Aug. 14, 2024
- Omega Fund Management 2024 Q1 filed May 14, 2024
- Omega Fund Management 2023 Q4 filed Feb. 14, 2024
- Omega Fund Management 2023 Q3 filed Nov. 14, 2023
- Omega Fund Management 2023 Q2 filed Aug. 14, 2023
- Omega Fund Management 2023 Q1 filed May 15, 2023
- Omega Fund Management 2022 Q4 filed Feb. 13, 2023
- Omega Fund Management 2022 Q3 filed Nov. 14, 2022
- Omega Fund Management 2022 Q2 filed Aug. 15, 2022
- Omega Fund Management 2022 Q1 filed May 13, 2022